To include your compound in the COVID-19 Resource Center, submit it here.

Oral hexyl-insulin monoconjugate 2 HIM2: Phase II

In a U.S. Phase II trial in 31 patients with Type I diabetes, daily mealtime

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE